(Q79846772)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008181%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

editorial

0 references

title

No justification for very high-dose enzyme therapy for patients with type III Gaucher disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008181%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

Ari Zimran

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008181%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Deborah Elstein

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008181%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 November 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008181%20AND%20SRC:MED&resulttype=core&format=json

Journal of Inherited Metabolic Disease

26 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008181%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008181%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008181%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

843-844

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008181%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10545-007-0783-8

26 December 2019

exact match

0 references

cites work

Outcome of type III Gaucher disease on enzyme replacement therapy: review of 55 cases.

1 reference

12 December 2020

Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis.

1 reference

12 December 2020

Simultaneous preimplantation genetic diagnosis for Tay–Sachs and Gaucher disease

1 reference

12 December 2020

Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease

1 reference

12 December 2020

Isolated horizontal supranuclear gaze palsy as a marker of severe systemic involvement in Gaucher's disease.

1 reference

12 December 2020

Consensus recommendations.

1 reference

12 December 2020

Low-dose therapy trumps high-dose therapy again in the treatment of Gaucher disease

1 reference

12 December 2020

Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry

1 reference

12 December 2020

Computerized cognitive testing in patients with type I Gaucher disease: effects of enzyme replacement and substrate reduction

1 reference

12 December 2020

Management of neuronopathic Gaucher disease: a European consensus.

1 reference

12 December 2020

Ethical considerations for enzyme replacement therapy in neuronopathic Gaucher disease.

1 reference

12 December 2020

Gaucher disease: enzyme therapy in the acute neuronopathic variant

1 reference

12 December 2020

Lysosomal storage diseases: natural history and ethical and economic aspects

1 reference

12 December 2020